SAM
Senzar Asset Management Portfolio holdings
AUM
$34.7M
This Quarter Return
+17.43%
1 Year Return
+0.55%
3 Year Return
-0.75%
5 Year Return
–
10 Year Return
–
AUM
$395M
AUM Growth
+$395M
(+4.7%)
Cap. Flow
+$4.5M
Cap. Flow
% of AUM
1.14%
Top 10 Holdings %
Top 10 Hldgs %
70.4%
Holding
40
New
10
Increased
13
Reduced
5
Closed
12
Top Buys
| 1 |
Halozyme
HALO
|
$29.3M |
| 2 |
Gilead Sciences
GILD
|
$21.8M |
| 3 |
BIVV
Bioverativ Inc. Common Stock
BIVV
|
$18.7M |
| 4 |
Sanofi
SNY
|
$13.8M |
| 5 |
TG Therapeutics
TGTX
|
$13.3M |
Top Sells
| 1 |
Eli Lilly
LLY
|
$40.3M |
| 2 |
SHPG
Shire pic
SHPG
|
$33.5M |
| 3 |
AGN
Allergan plc
AGN
|
$33.3M |
| 4 |
TSRO
TESARO, Inc.
TSRO
|
$19.1M |
| 5 |
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
|
$15.3M |
Sector Composition
| 1 | Healthcare | 93.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Sanofi
SNY
$121B
| $69.6M | 17.64% | 1,538,908 +304,708 | +25% | +$13.8M |
|
|
2
Halozyme
HALO
$8.56B
| $45.2M | 11.46% | 3,489,864 +2,264,420 | +185% | +$29.3M |
|
|
ESRX
3
DELISTED
Express Scripts Holding Company
ESRX
| $34.5M | 8.74% | 523,301 +76,300 | +17% | +$5.03M |
|
4
Elevance Health
ELV
$71.8B
| $28.2M | 7.14% | 170,450 -45,050 | -21% | -$7.45M |
|
|
5
Gilead Sciences
GILD
$140B
| $21.8M | 5.52% | +320,600 | New | +$21.8M |
|
|
BIVV
6
DELISTED
Bioverativ Inc. Common Stock
BIVV
| $18.7M | 4.74% | +343,800 | New | +$18.7M |
|
7
Abbott
ABT
$231B
| $17.2M | 4.35% | 386,800 +190,500 | +97% | +$8.46M |
|
8
MiMedx Group
MDXG
$1.05B
| $16.1M | 4.09% | 1,692,850 +447,300 | +36% | +$4.26M |
|
|
9
TG Therapeutics
TGTX
$4.65B
| $13.3M | 3.36% | +1,139,900 | New | +$13.3M |
|
10
Globus Medical
GMED
$8.27B
| $13.2M | 3.36% | +447,100 | New | +$13.2M |
|
|
FWP
11
DELISTED
Forward Pharma A/S American Depositary Shares
FWP
| $10.2M | 2.57% | +472,300 | New | +$10.2M |
|
12
Myriad Genetics
MYGN
$593M
| $9.96M | 2.52% | 518,800 +23,700 | +5% | +$455K |
|
|
LPNT
13
DELISTED
LifePoint Health, Inc.
LPNT
| $9.39M | 2.38% | +143,400 | New | +$9.39M |
|
14
Select Medical
SEM
$1.61B
| $8.84M | 2.24% | +662,200 | New | +$8.84M |
|
|
NDRM
15
DELISTED
NeuroDerm Ltd. Ordinary Shares
NDRM
| $8.59M | 2.18% | 323,700 +136,900 | +73% | +$3.63M |
|
16
Tenet Healthcare
THC
$16.3B
| $8.58M | 2.17% | +484,300 | New | +$8.58M |
|
17
Viatris
VTRS
$12.3B
| $8.45M | 2.14% | +216,700 | New | +$8.45M |
|
18
Travere Therapeutics
TVTX
$1.56B
| $7.94M | 2.01% | 430,189 -62,700 | -13% | -$1.16M |
|
19
Orthofix Medical
OFIX
$592M
| $7.21M | 1.83% | 188,908 +77,533 | +70% | +$2.96M |
|
|
CNCE
20
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $7.11M | 1.8% | 416,845 +16,257 | +4% | +$277K |
|
|
DPLO
21
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
| $7.1M | 1.8% | +445,200 | New | +$7.1M |
|
|
CORI
22
DELISTED
Corium International, Inc.
CORI
| $6.3M | 1.6% | 1,508,266 -68,500 | -4% | -$286K |
|
|
ALDR
23
DELISTED
Alder Biopharmaceuticals, Inc.
ALDR
| $4.47M | 1.13% | 215,070 +90,500 | +73% | +$1.88M |
|
|
MNTA
24
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $4.18M | 1.06% | 313,296 -218,602 | -41% | -$2.92M |
|
|
ARNA
25
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $2.85M | 0.72% | 1,952,891 +75,400 | +4% | +$110K |
|